glp-1's GLP-1 Agonists: A Comprehensive Overview GLP-1 for Weight Loss and
Description
however, in other infusion studies with the GLP-1 receptor agonist exenatide, measured GFR (mGFR) was increased in healthy volunteers (26) and unchanged in people with T2D (30)
doi: 10.1097/ALN.0000000000000320
This is a significant quality-of-life outcome, as CPAP adherence is a persistent challenge, studies estimate that 30 to 50 percent of patients prescribed CPAP do not use it consistently
doi: 10.2337/db07-1344
10.1016/S0140-6736(12)60691-6 25
In December 2025, the FDA approved a new Wegovy pill, also manufactured by Novo Nordisk, for weight loss treatment
